13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001012975-26-000133
Total Value
$258.7M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 1,372,425 | $63.3M | 24.48% |
| 2 | OCULIS HOLDING AG | OCSAW | 2,288,658 | $45.7M | 17.67% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,366,624 | $39.7M | 15.34% |
| 4 | EVOMMUNE INC | EVMN | 1,926,943 | $33.0M | 12.75% |
| 5 | ZENAS BIOPHARMA INC | ZBIO | 591,991 | $21.5M | 8.31% |
| 6 | TREVI THERAPEUTICS INC | TRVI | 1,256,782 | $15.7M | 6.08% |
| 7 | IMMUNOME INC | IMNM | 732,512 | $15.7M | 6.08% |
| 8 | MAPLIGHT THERAPEUTICS INC | MPLT | 611,447 | $10.7M | 4.15% |
| 9 | BIOAGE LABS INC | BIOA | 653,374 | $8.6M | 3.34% |
| 10 | RECURSION PHARMACEUTICALS IN | RXRX | 595,518 | $2.4M | 0.94% |
| 11 | RALLYBIO CORP | RLYB | 2,404,644 | $1.6M | 0.64% |
| 12 | BOLT BIOTHERAPEUTICS INC | BOLT | 94,573 | $517,125 | 0.20% |